Growth Metrics

Scansource (SCSC) Cash & Equivalents (2016 - 2025)

Scansource (SCSC) has disclosed Cash & Equivalents for 17 consecutive years, with $83.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 24.48% to $83.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $83.5 million through Dec 2025, down 24.48% year-over-year, with the annual reading at $126.2 million for FY2025, 31.98% down from the prior year.
  • Cash & Equivalents hit $83.5 million in Q4 2025 for Scansource, down from $124.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $185.5 million in Q2 2024 to a low of $34.1 million in Q4 2021.
  • Historically, Cash & Equivalents has averaged $81.6 million across 5 years, with a median of $59.1 million in 2021.
  • Biggest five-year swings in Cash & Equivalents: tumbled 49.21% in 2021 and later soared 412.63% in 2024.
  • Year by year, Cash & Equivalents stood at $34.1 million in 2021, then surged by 94.72% to $66.4 million in 2022, then crashed by 32.29% to $45.0 million in 2023, then soared by 145.67% to $110.5 million in 2024, then decreased by 24.48% to $83.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for SCSC at $83.5 million in Q4 2025, $124.9 million in Q3 2025, and $126.2 million in Q2 2025.